Phase II Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

What is the purpose of this trial?

Phase II trial of nivolumab in 120 treatment naïve patients with ccRCC



Hoosier Cancer Research Network, Inc

Start Date: 05/10/2019

End Date: 02/01/2020

Last Updated: 05/13/2019

Study HIC#: 2000022534

Get Involved

For more information about this study, contact:
Neta Shanwetter Levit
+1 203-737-6247
neta.shanwetterlevit@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Michael Hurwitz

Principal Investigator

Sub-Investigators